BLTE — Belite Bio, Inc stock price, charts and financials

QT80Belite Bio, Inc

Belite Bio, Inc (NASDAQ: BLTE) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
157.27
+2.48+1.60%
BLTEQT80Belite Bio, Inc·NASDAQ
157.27+1.60%

Latest SEC Filings

Form category
Filing DateFormDescriptionFilingDocument
Jun 22, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 15, 20266-KForeign issuer report
May 20, 20266-KForeign issuer report
May 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 08, 20264Statement of changes in beneficial ownership
May 07, 20264Statement of changes in beneficial ownership
May 06, 20264Statement of changes in beneficial ownership
May 05, 20264Statement of changes in beneficial ownership
May 04, 20264Statement of changes in beneficial ownership
May 01, 20264Statement of changes in beneficial ownership
Apr 30, 20264Statement of changes in beneficial ownership
Apr 29, 20264Statement of changes in beneficial ownership
Apr 28, 20264Statement of changes in beneficial ownership
Apr 27, 20264Statement of changes in beneficial ownership
Apr 24, 20264Statement of changes in beneficial ownership
Apr 23, 20264Statement of changes in beneficial ownership
Apr 23, 20264Statement of changes in beneficial ownership
Apr 23, 20264Statement of changes in beneficial ownership
Apr 23, 20264Statement of changes in beneficial ownership
Apr 22, 20264Statement of changes in beneficial ownership
Apr 21, 20264Statement of changes in beneficial ownership
Apr 21, 20266-KForeign issuer report
Apr 20, 20264Statement of changes in beneficial ownership
Apr 20, 20264Statement of changes in beneficial ownership